Bright Green CORP

Bright Green Corporation has filed a proposed Chapter 11 Plan of Reorganization, seeking to restructure the company and pay creditors in full while allowing existing equity shareholders to retain their interests.

Bright Green Corporation has filed for Chapter 11 bankruptcy to implement a prepackaged restructuring plan, including a shift away from cannabis and towards the production of DEA scheduled controlled substances.

Bright Green Corporation has entered into a Restructuring Support Agreement with its major shareholder and plans to file for Chapter 11 bankruptcy to reorganize the company.

Bright Green Corporation has announced a significant restructuring, including the resignation of key executives and board members, and the appointment of Lynn Stockwell as CEO, alongside a new strategic focus on plant-based controlled substances.

Bright Green Corporation's 2024 Annual Meeting saw shareholders elect directors, approve a reverse stock split, authorize stock issuance, and ratify the accounting firm.

Bright Green Corporation has entered into an amended credit agreement, securing a minimum of $2.5 million in new funding and providing a conversion option into preferred stock.

Bright Green Corporation's Q3 2024 report highlights ongoing efforts to establish its federally-authorized cannabis business, with no revenue reported and continued focus on facility development and regulatory compliance.

Bright Green Corporation reported its Q2 2024 results, highlighting ongoing development and strategic shifts towards plant-based medicines, while navigating financial challenges.

Bright Green Corporation, a federally authorized cannabis company, reported its first quarter 2024 results with a net loss of $949,450 and no revenue, while continuing to develop its facilities and expand into other controlled substances.

Bright Green Corporation filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.

Bright Green Corporation's 10-K filing details its authorized capital, stock structure, anti-takeover provisions, and business plans in the federally authorized cannabis and plant-based medicine space.

Saleem Elmasri, CFO of Bright Green Corp, reports selling shares of common stock in open market transactions on September 9 and 10, 2024.

Saleem Elmasri, CFO of Bright Green Corp, reports selling shares of common stock in open market transactions on September 5th and 6th, 2024.

Gurvinder Singh, CEO of Bright Green Corp, amends a previous SEC filing to accurately reflect the grant and subsequent cancellation of restricted stock units and stock options.

Sean Deson, a director at Bright Green Corp, filed an amendment to a previous Form 4 to accurately report the grant of restricted stock units.

Saleem Elmasri, CFO of Bright Green Corp, reports selling 398,773 shares of common stock in open market transactions.

Saleem Elmasri, CFO of Bright Green Corp, amends a previous Form 4 filing to accurately report the grant of restricted stock units.

Bright Green Corporation is holding its annual meeting on November 15, 2024, to vote on key proposals including a reverse stock split, stock issuance upon conversion of preferred stock, and ratification of the company's accounting firm.